Endocrine-Based Therapy for HR-Positive Breast Cancer — Proceedings from a San Antonio 2025 Symposium Series
Get every episode summarized
Each time Breast Cancer Update publishes, we email you a written briefing from the transcript — the topics, who appeared, and any specific claims, with the ad reads skipped.
Email me new episodesFree for 3 shows. No card needed.
About this episode
Dr Angela DeMichele from the Abramson Cancer Center in Philadelphia, Pennsylvania, Dr Komal Jhaveri from Memorial Sloan Kettering Cancer Center in New York, New York, Dr Erica Mayer from Dana-Farber Cancer Institute in Boston, Massachusetts, Dr Hope S Rugo from City of Hope Comprehensive Cancer Center in Duarte, California, and Dr Seth Wander from Massachusetts General Hospital in Boston discuss real-world cases and recent clinical data surrounding the management of HR-positive breast cancer.
CME information and select publications here.
Get every episode summarized
Each time Breast Cancer Update publishes, we email you a written briefing from the transcript — the topics, who appeared, and any specific claims, with the ad reads skipped.
Email me new episodesFree for 3 shows. No card needed.
Hosts & guests
No transcript yet
This episode has not been transcribed. Request it and it moves to the front of the queue.
More episodes
More from Breast Cancer Update
Breast Cancer — 5-Minute Journal Club Issue 2 with Dr Lajos Pusztai: Current and...
Breast Cancer Update
Desmoid Tumors — Microlearning Activity 1 with Dr Ravin Ratan
Breast Cancer Update
Antibody-Drug Conjugates for Breast Cancer — Year in Review Series on Relevant N...
Breast Cancer Update
HER2-Positive Breast Cancer — Proceedings from a San Antonio 2025 Symposium Seri...
Breast Cancer Update